Initial Rate for Sodium Bicarbonate Drip
For continuous sodium bicarbonate infusion requiring ongoing alkalinization, start at 1-3 mL/kg/hour using a 150 mEq/L solution after an initial bolus. 1, 2
Preparation of Infusion Solution
- Prepare a 150 mEq/L (isotonic) solution by diluting standard 8.4% sodium bicarbonate (1000 mEq/L) approximately 1:6 with sterile water or normal saline. 1
- The 4.2% concentration (approximately 500 mEq/L) can be further diluted 1:3 to achieve the 150 mEq/L target for continuous infusion. 1
- No commercially available premixed isotonic bicarbonate solutions exist in the United States, requiring pharmacy compounding with careful attention to avoid preparation errors. 1
Initial Bolus Dosing (Before Starting Drip)
- Administer 1-2 mEq/kg IV as a slow bolus over several minutes before initiating continuous infusion. 1, 2
- For sodium channel blocker/tricyclic antidepressant toxicity specifically, give 50-150 mEq as initial bolus using hypertonic solution (1000 mEq/L). 1, 3
- In pediatric patients under 2 years, use only 0.5 mEq/mL (4.2%) concentration for the initial bolus, achieved by diluting 8.4% solution 1:1 with normal saline. 1
Continuous Infusion Rate
- Start at 1-3 mL/kg/hour of the 150 mEq/L solution for ongoing alkalinization needs. 1
- For a 70 kg adult, this translates to approximately 70-210 mL/hour of the 150 mEq/L solution. 1
- The FDA label suggests 2-5 mEq/kg over 4-8 hours for less urgent metabolic acidosis, which approximates to similar hourly rates when calculated. 2
Critical Synergistic Requirement: Hyperventilation
- Maintain mechanical ventilation with PaCO2 of 30-35 mmHg (4.0-4.7 kPa) to work synergistically with bicarbonate for serum alkalinization. 1, 3
- This hyperventilation strategy reduces the total dose of bicarbonate needed and minimizes adverse effects from excessive sodium bicarbonate administration. 3
- Bicarbonate generates CO2 that must be eliminated; giving it without adequate ventilation causes paradoxical intracellular acidosis. 1
Target Parameters and Monitoring
- Target arterial pH of 7.45-7.55 for sodium channel blocker toxicity, or pH 7.2-7.3 for severe metabolic acidosis. 1, 3
- Do not exceed serum sodium of 150-155 mEq/L or pH of 7.50-7.55 in non-toxicologic scenarios. 1
- Monitor arterial blood gases, serum electrolytes (sodium, potassium, ionized calcium) every 2-4 hours during active infusion. 1
Maximum Dosing Limits to Prevent Toxicity
- Never exceed 6 mEq/kg total cumulative dose, as this commonly causes hypernatremia, fluid overload, metabolic alkalosis, and cerebral edema. 1, 3
- For a 70 kg adult, the maximum total dose is approximately 420 mEq (420 mL of 8.4% solution or 2800 mL of 150 mEq/L solution). 3
Specific Clinical Scenarios
Sodium Channel Blocker/TCA Toxicity
- After initial bolus of 50-150 mEq, continue infusion at 1-3 mL/kg/hour of 150 mEq/L solution until QRS narrowing and hemodynamic stability achieved. 1
- Titrate to resolution of QRS prolongation (not necessarily <100 ms) and hypotension, targeting pH 7.45-7.55. 1, 3
Severe Metabolic Acidosis (pH <7.1)
- After initial 1-2 mEq/kg bolus, the FDA recommends stepwise approach over 4-8 hours rather than continuous high-rate infusion. 2
- Repeat boluses of 50 mEq every 5-10 minutes guided by arterial blood gas monitoring may be more appropriate than continuous drip in cardiac arrest scenarios. 2
Diabetic Ketoacidosis (pH <6.9)
- Infuse 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/hour (this is approximately 250 mEq/L solution at 200 mL/hour). 1
- For pH 6.9-7.0, use 50 mmol in 200 mL at 200 mL/hour. 1
Critical Safety Considerations
- Flush IV line with normal saline before and after bicarbonate to prevent inactivation of simultaneously administered catecholamines. 1
- Never mix with calcium-containing solutions or vasoactive amines (causes precipitation or inactivation). 1
- Monitor and aggressively replace potassium, as bicarbonate shifts potassium intracellularly causing potentially severe hypokalemia. 1
- Monitor ionized calcium, especially with doses >50-100 mEq, as large doses acutely decrease free ionized calcium. 1
When NOT to Use Continuous Bicarbonate Infusion
- Do not use for hypoperfusion-induced lactic acidemia with pH ≥7.15 in sepsis—no benefit demonstrated and potential harm. 1, 4
- Avoid in rhabdomyolysis—associated with higher AKI incidence, dialysis dependency, 30-day mortality, and longer hospital stays. 4
- Contraindicated without adequate ventilation—will worsen intracellular acidosis due to CO2 accumulation. 1
Common Pitfalls to Avoid
- Do not dose to achieve QRS <100 ms—this leads to excessive dosing, as QRS normalization takes hours and prolonged QRS is not specific for sodium channel blockade. 3
- Do not attempt complete pH normalization in first 24 hours—lag in ventilatory readjustment causes unrecognized alkalosis. 2
- Do not use in patients with inadequate ventilatory capacity—bicarbonate produces CO2 requiring elimination. 1
- Do not combine potassium-sparing diuretics with bicarbonate therapy without close monitoring—risk of severe hyperkalemia. 5